Pennycents Celebrates Successful Relaunch of Penny Stock Magazine

PC Capital Holdings celebrated the re-launch of its flagship product, Pennycents Magazine, the only unbiased Penny Stock magazine printed and delivered monthly to subscribers. In addition, the inclusion of daily commentary on its website has continued to attract investors who want to learn about OTCBB companies without an agenda.

President Chris Abbott shared at a recent interview, "With an anticipated February circulation of over 13,000 issues, we have indeed identified the need of small cap investors and their thirst for unbiased information on penny stocks, here's to a strong 2008 and the companies that will lead it"

In addition to the monthly magazine, the website www.pennycents.com provides daily columns on recent events in the news.

Below is an excerpt of the Monday's daily columns.

by Priya Nigam

The worldwide in-vitro diagnostics (IVD) industry is growing rapidly. The market for IVD products is expected to reach $20 billion by 2011. With the emerging economies gaining momentum, the demand for medical facilitates is surging. This, in turn, is boosting the demand for IVD products and services.

Avitar Inc (http://www.avitarinc.com) is a diagnostics company that provides medical devices for drugs-of-abuse testing and disease and clinical testing services. The company's two main products are ORALscreen, for oral drugs-of-abuse testing, and Hydrasorb, an absorbent dressing for moderate to heavy exudating wounds.

Sales from continuing operations plummeted 31% to $3.1 million in fiscal 2007, ended September 30. Avitar cited its shift to a new US distributor for Hydrasorb as the main reason for the downturn in sales. The company's net losses contracted to $2.26 million, or $0.09 per share, from $3.70 million, or $0.80 per share, in fiscal 2006.

Avitar faces a $1.5 billion existing market in the US. However, given the current macroeconomic scenario, the company is aware of the importance of having a global presence. Currently, the overseas market represents about 10% of its sales revenue and the company's latest moves have been to grow this market.

Avitar said earlier last week that several major international companies in Canada were converting from the use of traditional urine-based drug testing to its ORALscreen onsite test for drugs-of-abuse. The company's Chairman and CEO, Peter Phildius, said, "We are very pleased with the response that our Canadian distribution partner and our ORALscreen technology are receiving from major international corporations and their suppliers. Together we have identified opportunities that could generate up to $500,000 in sales over the next twelve months as these companies begin to convert from urine-based testing to our on-site oral fluid drug tests."

In the first week of January, Avitar announced that ORALscreen had been approved by the Egyptian government to be used by several ministries, beginning with the Ministry of Tourism. Referring to the potential offered by the country, Phildius said, "Egypt's population of 75 million is growing twice as fast as the US."

Although Avitar is focusing on growth and expanding its international presence, insiders control merely 0.07% of the company, which is not particularly a good sign. Avitar was active on the private placement front last year and its shares have been sliding steadily since March. Having hit a high of $0.03 in late-February, the company's shares are currently trading below $0.003.

About Pennycents Magazine

Pennycents is a mailed monthly magazine featuring Penny Stock (http://www.pennycents.com) companies listed primarily on the OTCBB (http://www.pennycents.com) and Pink Sheets (http://www.pennycents.com), as well as on Nasdaq, the NYSE, and the AMEX. This independent magazine features information-based articles on publicly-traded reporting companies. Neither Pennycents, its staff or its writers are allowed to invest in companies featured in Pennycents for a period of at least 60 days from the issue publication date. Pennycents does not accept payment from the companies that are the subjects of its articles or columns. It is the Mission of Pennycents Magazine to be a truly unbiased Penny Stock information platform. You can have Pennycents mailed to your door or learn more by visiting its Penny Stock Columns (http://www.pennycents.com/ver04/columns.html) .

Pennycents does, however, sell advertising space in our Magazine to public companies that would like to feature a product or service of their company. Advertising costs are available publicly on our website. To Advertise in Pennycents Magazine, please visit our website, or contact chris@pennycents.com.

PC Capital Holdings, LLC (Pennycents (http://www.pennycents.com)) believes the information contained herein to be accurate and reliable as of the issue publication date. The information contained herein is not guaranteed or warranted by Pennycents to be accurate, and should not be considered to be all-inclusive. The companies that are written about in Pennycents have not approved the statements made in this disclaimer. Information contained herein may contain forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or a solicitation of an offer to buy or sell securities. Pennycents is a magazine and not a licensed broker, broker/dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a licensed broker before purchasing or selling any securities viewed on http://www.pennycents.com or mentioned herein.

CONTACT: Chris Abbott, Pennycents Magazine

Tel: +1 941 961 0876

e-mail: chris@pennycents.com

↑ Grab this Headline Animator

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Service | Digital Fuel | service level management |

4886 readers online...

, Local News

Subscribe in a reader